QurCan Therapeutics Inc.

QurCan Therapeutics (formerly Nanology Labs Inc) is a biotechnology company using advanced nanoparticle drug-delivery technology to unleash the immense potential of next-generation biological and genetic medicine and deliver life-changing therapeutics. QurCan's next generation nanoparticle platform, TERP, enables tissue-selective delivery of nucleotides and biological therapeutics to extra-hepatic sites, including brain and spleen. TERP technology is a breakthrough technology with the great potential to deliver a new era of disease-modifying genetic medicine that will make a difference to patients with a wide range of unmet medical needs.

Website

http://www.qurcan.com

External link for QurCan Therapeutics Inc.

Industry

Pharmaceutical Manufacturing

Company size

1 employee

Headquarters

Toronto, ON

Type

Privately Held

Founded

2018

Specialties

Gene Delivery, CNS delivery, Tissue targeting, and nanoparticle technology